Cognitive Function: The Role of Genetics in Preventing Cognitive Decline

Cognitive function refers to the set of mental processes that allow humans to understand, learn, remember, solve problems, and make decisions. It is the invisible mechanism behind every thought, word, and action—from remembering where we left our keys to solving a professional issue. However, it is not static. Like a muscle that strengthens or weakens depending on how it is used, the brain responds to stimuli, habits, and biological influences.

What does cognitive function include?

The core abilities that make up our cognitive capacity are diverse and interrelated. Memory, for example, allows us to store and recall information, whether it is something we just read (short-term memory) or past experiences and acquired knowledge (long-term memory). Attention is the ability to selectively focus on a stimulus or task, ignoring distractions—a kind of mental filter that helps us stay focused. Language skills involve the comprehension and production of speech, both spoken and written. These are our tools for communication, expression, and understanding others. More complex processes such as planning, decision-making, problem-solving, and cognitive flexibility form what we call executive functions—essentially the brain’s “control center.” Lastly, visuospatial perception helps us navigate our environment, locate objects around us, perceive distances and directions, and move safely and accurately through space.

What affects cognitive function?

Cognitive function does not remain constant throughout life. On the contrary, it is continuously shaped by a complex set of interacting factors. One of the most obvious factors is age. As we grow older, it is natural to experience some decline in functions such as information processing speed. Among the most modifiable factors is diet. Numerous studies have shown that a diet rich in omega-3 fatty acids, antioxidants, and B-complex vitamins can significantly contribute to maintaining cognitive health. Physical activity, in turn, enhances blood circulation to the brain and promotes neuroplasticity—the brain’s ability to reorganize and adapt. Likewise, sleep is essential for memory, learning, and concentration. Both its duration and quality play a crucial role in cognitive performance. Mental health also cannot be overlooked. Chronic stress, depression, and anxiety have a proven negative impact on concentration, decision-making, and memory recall. Environmental factors such as exposure to toxic substances (e.g., heavy metals, pesticides), social isolation, and medical conditions like Alzheimer’s disease, strokes, type 2 diabetes, and hypertension are all potential risk factors for cognitive decline. Finally, genetic predisposition plays a critical role. Today, genetic science allows us to identify specific genetic variants associated with an increased risk of developing cognitive disorders, offering the opportunity for more personalized prevention and intervention strategies.

How can genetic predisposition be detected?

One of the most extensively studied genes related to cognitive health is APOE (Apolipoprotein E). This gene plays a key role in lipid metabolism in the brain and has three major alleles: e2, e3, and e4. APOE e2 appears to offer some protection against decline, while APOE e3 is the most common and considered “neutral” in terms of risk. Carriers of APOE e4, however, have a higher likelihood of experiencing cognitive decline or even developing Alzheimer’s disease at some point in their lives. Still, this does not constitute a diagnosis—it is merely an indication of predisposition. Just like someone with a family history of high cholesterol undergoes more frequent blood tests, knowing your genetic predisposition to cognitive decline gives you a head start in prevention.

At our center, through DNA analysis performed easily with a small saliva sample, we examine, among other things, this particular gene. This allows us to detect the presence of the e4 allele and assess the likelihood of increased cognitive decline risk. This test is a valuable tool for prevention. Don’t wait for symptoms to appear—take control early!

Βιβλιογραφία – References 

Dhakal A, Bobrin BD. Cognitive Deficits. 2023 Feb 14. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 32644478. https://www.ncbi.nlm.nih.gov/books/NBK559052/ 

Evans IEM, Martyr A, Collins R, Brayne C, Clare L. Social Isolation and Cognitive Function in Later Life: A Systematic Review and Meta-Analysis. J Alzheimers Dis. 2019;70(s1):S119-S144. doi: 10.3233/JAD-180501. PMID: 30372678; PMCID: PMC6700717.

Suh SW, Lim E, Burm SY, Lee H, Bae JB, Han JW, Kim KW. The influence of n-3 polyunsaturated fatty acids on cognitive function in individuals without dementia: a systematic review and dose-response meta-analysis. BMC Med. 2024 Mar 12;22(1):109. doi: 10.1186/s12916-024-03296-0. PMID: 38468309; PMCID: PMC10929146.

Lucey BP, Wisch J, Boerwinkle AH, Landsness EC, Toedebusch CD, McLeland JS, Butt OH, Hassenstab J, Morris JC, Ances BM, Holtzman DM. Sleep and longitudinal cognitive performance in preclinical and early symptomatic Alzheimer's disease. Brain. 2021 Oct 22;144(9):2852-2862. doi: 10.1093/brain/awab272. PMID: 34668959; PMCID: PMC8536939.

Bliss ES, Wong RH, Howe PR, Mills DE. Benefits of exercise training on cerebrovascular and cognitive function in ageing. J Cereb Blood Flow Metab. 2021 Mar;41(3):447-470. doi: 10.1177/0271678X20957807. Epub 2020 Sep 20. PMID: 32954902; PMCID: PMC7907999.

Tavares VDO, Rossell SL, Schuch FB, Herring M, Menezes de Sousa G, Galvão-Coelho NL, Hallgren M. Effects of exercise on cognitive functioning in adults with serious mental illness: A meta analytic review. Psychiatry Res. 2023 Mar;321:115081. doi: 10.1016/j.psychres.2023.115081. Epub 2023 Feb 1. PMID: 36780866.

Clare L, Wu YT, Teale JC, MacLeod C, Matthews F, Brayne C, Woods B; CFAS-Wales study team. Potentially modifiable lifestyle factors, cognitive reserve, and cognitive function in later life: A cross-sectional study. PLoS Med. 2017 Mar 21;14(3):e1002259. doi: 10.1371/journal.pmed.1002259. PMID: 28323829; PMCID: PMC5360216.

Raulin AC, Doss SV, Trottier ZA, Ikezu TC, Bu G, Liu CC. ApoE in Alzheimer's disease: pathophysiology and therapeutic strategies. Mol Neurodegener. 2022 Nov 8;17(1):72. doi: 10.1186/s13024-022-00574-4. PMID: 36348357; PMCID: PMC9644639.

Windham IA, Cohen S. The cell biology of APOE in the brain. Trends Cell Biol. 2024 Apr;34(4):338-348. doi: 10.1016/j.tcb.2023.09.004. Epub 2023 Oct 5. PMID: 37805344; PMCID: PMC10995109.

Belloy ME, Andrews SJ, Le Guen Y, Cuccaro M, Farrer LA, Napolioni V, Greicius MD. APOE Genotype and Alzheimer Disease Risk Across Age, Sex, and Population Ancestry. JAMA Neurol. 2023 Dec 1;80(12):1284-1294. doi: 10.1001/jamaneurol.2023.3599. PMID: 37930705; PMCID: PMC10628838.